Syphilis occupies an unsettling place in ophthalmology. It is uncommon, protean, vision-threatening, and treatable. Although only about 0.6% of syphilis patients manifest ocular disease, the consequences of a missed diagnosis are severe. For generations, the imperative has been simple: do not miss syphilis.
Yet, when residents turn to our most authoritative educational source, the Basic and Clinical Science Course (BCSC), they encounter an inconsistent message:
“Syphilitic uveitis is confirmed through serologic testing, The traditional screening algorithm for syphilis uses a nontreponemal assay (eg, the nonspecific but quantitative VDRL or rapid plasma reagin [RPR] test) for primary evaluation and if the test is reactive, a treponemal assay (eg, fluorescent treponemal antibody absorption [FTA-ABS] test…) for confirmation. More recently, laboratories have reversed the order in which treponemal and nontreponemal tests are performed, leading to the development of the reverse sequence syphilis screening (RSSS) algorithm. Although the CDC currently continues to recommend the traditional testing approach, it provides a recommended algorithm for the use of RSSS. Briefly, initial testing is done with a treponemal assay, followed by a quantitative nontreponemal test for quantitation. Discordant samples are resolved on the basis of a second treponemal assay.”
The text describes both the traditional and reverse screening algorithms without endorsing one for ophthalmic disease. This ambiguity suggests that the 2 sequences are interchangeable options based on preference. They are not. In fairness, this topic is correctly addressed in 2 other locations in the BCSC , ; but it is too important for inconsistency to be tolerated.
The persistence of dual algorithms represents an unspoken conflict between population-oriented logic (prioritizing specificity and cost) and patient-centered ethics (prioritizing sensitivity). In primary care, the traditional algorithm persists for valid public health reasons. In ophthalmology, however, it is structurally destined to fail. The distinction between these algorithms is not preference or convention, but their stage-dependent sensitivity—an issue that becomes decisive in the different temporal windows in which ophthalmologists encounter syphilis compared to primary care doctors.
The Sensitivity Gap
The traditional algorithm begins with a nontreponemal test. If nonreactive, testing stops. This protocol was designed for public health screening in high-prevalence populations in which the goal is to identify active, infectious cases (secondary syphilis) while minimizing false- positive results. In that context, for example, the patient with a palmar rash and high bacterial load, the RPR is nearly 100% sensitive.
But ophthalmologists rarely see “classic” secondary syphilis. We see the outliers: early primary cases in which antibodies have not yet formed, or late/latent stages in which nontreponemal titers have waned. In these windows, the RPR is fallible.
-
•
In primary syphilis: RPR sensitivity is around 49% to 76%, , meaning that the traditional sequence misses one quarter to one half of early cases.
-
•
In late/latent stages: RPR sensitivity has been reported to be 61%.
-
•
In ocular syphilis: Published series suggest that up to 32% of patients with treponemal-positive ocular syphilis present with a nonreactive RPR. ,,
If an ophthalmologist follows the traditional algorithm for these patients and the screening test returns negative, the workup might stop, treatment may be delayed or not given, and the patient could lose vision.
Why the Disconnect?
Why does the CDC continue to recommend a protocol that misses 32% of our patients? Because they are not writing guidelines for uveitis specialists: they are writing for primary care and emergency physicians. Generalists operate in a high-volume environment where the case mix favors the traditional approach. Their patients often present with rashes or chancres or for routine sexually transmitted infection screening. For them, a miss is rare, remediable with follow-up, and the false-positive results of the RSSS create a burden of nuisance referrals.
Ophthalmology occupies a different ethical position. The base rate of syphilis in a uveitis clinic is low, but the cost of a miss is vision loss and potentially life-threatening consequences of untreated neurosyphilis. In this setting, the calculus shifts toward sensitivity. We can tolerate false positives; we cannot tolerate false negatives.
The Confusion Fallacy
Critics of the RSSS argue that starting with a treponemal test creates confusion by identifying patients with previously treated, inactive infections. This argument overestimates the burden of ambiguity while downplaying the clinical risk. Diagnostic ambiguity is not itself harm. It can usually be resolved with history taking (“Have you been treated for syphilis before?”), chart review, or consultation. Optic neuropathy cannot be resolved . The ethical error lies not in ordering too many tests, but in allowing an algorithm designed for population-level public health economics to obscure clinical judgment.
The Role of Simultaneous Testing
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
